# CARE Initiative: Real-world Emulation of the PALOMA-2 Trial

> **NCT06607601** · — · COMPLETED · sponsor: **Aetion, Inc.** · enrollment: 724 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Palbociclib
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT06607601
- **Lead sponsor:** Aetion, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-01
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-07-20
- **Target enrollment:** 724 (ACTUAL)
- **Last updated:** 2024-09-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607601, "CARE Initiative: Real-world Emulation of the PALOMA-2 Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06607601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*